» Articles » PMID: 38921681

Contrast-Enhanced Magnetic Resonance Imaging Based T1 Mapping and Extracellular Volume Fractions Are Associated with Peripheral Artery Disease

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Extracellular volume fraction (ECV), measured with contrast-enhanced magnetic resonance imaging (CE-MRI), has been utilized to study myocardial fibrosis, but its role in peripheral artery disease (PAD) remains unknown. We hypothesized that T1 mapping and ECV differ between PAD patients and matched controls.

Methods And Results: A total of 37 individuals (18 PAD patients and 19 matched controls) underwent 3.0T CE-MRI. Skeletal calf muscle T1 mapping was performed before and after gadolinium contrast with a motion-corrected modified look-locker inversion recovery (MOLLI) pulse sequence. T1 values were calculated with a three-parameter Levenberg-Marquardt curve fitting algorithm. ECV and T1 maps were quantified in five calf muscle compartments (anterior [AM], lateral [LM], and deep posterior [DM] muscle groups; soleus [SM] and gastrocnemius [GM] muscles). Averaged peak blood pool T1 values were obtained from the posterior and anterior tibialis and peroneal arteries. T1 values and ECV are heterogeneous across calf muscle compartments. Native peak T1 values of the AM, LM, and DM were significantly higher in PAD patients compared to controls (all < 0.028). ECVs of the AM and SM were significantly higher in PAD patients compared to controls (AM: 26.4% (21.2, 31.6) vs. 17.3% (10.2, 25.1), = 0.046; SM: 22.7% (19.5, 27.8) vs. 13.8% (10.2, 19.1), = 0.020).

Conclusions: Native peak T1 values across all five calf muscle compartments, and ECV fractions of the anterior muscle group and the soleus muscle were significantly elevated in PAD patients compared with matched controls. Non-invasive T1 mapping and ECV quantification may be of interest for the study of PAD.

Citing Articles

Contrast-Enhanced Magnetic Resonance Imaging Based T1 Mapping and Extracellular Volume Fractions Are Associated with Peripheral Artery Disease.

Fitian A, Shieh M, Gimnich O, Belousova T, Taylor A, Ballantyne C J Cardiovasc Dev Dis. 2024; 11(6).

PMID: 38921681 PMC: 11203653. DOI: 10.3390/jcdd11060181.

References
1.
Messroghli D, Rudolph A, Abdel-Aty H, Wassmuth R, Kuhne T, Dietz R . An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging. 2010; 10:16. PMC: 2919441. DOI: 10.1186/1471-2342-10-16. View

2.
Martelli E, Enea I, Zamboni M, Federici M, Bracale U, Sangiorgi G . Focus on the Most Common Paucisymptomatic Vasculopathic Population, from Diagnosis to Secondary Prevention of Complications. Diagnostics (Basel). 2023; 13(14). PMC: 10377859. DOI: 10.3390/diagnostics13142356. View

3.
Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S . MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep. 2014; 4:5621. PMC: 4085628. DOI: 10.1038/srep05621. View

4.
Brunner G, Bismuth J, Nambi V, Ballantyne C, Taylor A, Lumsden A . Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease. Med Biol Eng Comput. 2016; 54(11):1667-1681. PMC: 5152942. DOI: 10.1007/s11517-016-1457-1. View

5.
Yang E, Ghosn M, Khan M, Gramze N, Brunner G, Nabi F . Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis. Circ Cardiovasc Imaging. 2019; 12(12):e009535. PMC: 7529265. DOI: 10.1161/CIRCIMAGING.119.009535. View